Japanese scientists said they conducted experiments and came up with a new way to determine the severity of the course of a new type of coronavirus. According to experts, their method is based on the analysis of patients’ urine, according to NHK TV channel.
Experts have established a relationship between the concentration of markers of kidney damage – special proteins contained in urine with low oxygen intake – with changes in symptoms of patients with COVID-19, which initially passed in a mild form.
41 people took part in the testing. Scientists found that out of 13 patients with an increased concentration of L-FABP protein in urine, eight felt significantly worse within a week, and two of them needed a connection to a ventilator.
At the same time, no worsening of symptoms was observed in another 28 people with a concentration of L-FABP in urine that did not exceed the norm.
At the same time, an increase in the concentration of the L-FABP protein, which binds liver fatty acids, in itself speaks of acute renal damage, which poses a risk for complications.
Note that the level of L-FABP in the urine of healthy people is 16 nanograms per milliliter.